Terapia Génica en Enfermedad de Parkinson
PARKBA SAL
![Foto de Terapia Génica en Enfermedad de Parkinson](/img/uploaded/2e47307b33b4171dbd01aab57609e63c.jpg)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Clínica Universitaria de Navarra (7)
2023
-
Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome
Journal of Molecular Medicine, Vol. 101, Núm. 12, pp. 1587-1601
2021
2011
-
Adeno-associated virus liver transduction efficiency measured by in vivo [ 18F]FHBG positron emission tomography imaging in rodents and nonhuman primates
Human Gene Therapy, Vol. 22, Núm. 8, pp. 999-1009
2008
-
Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys
Movement Disorders, Vol. 23, Núm. 5, pp. 708-715
2004
-
How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)
Trends in Neurosciences
-
The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits
Neurology, Vol. 62, Núm. 1 SUPPL. 1
2000
-
Pathophysiology of the basal ganglia in Parkinson's disease
Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.